Tailored Expertise Sourcing & Market Intelligence in Global Consulting

La France va-t-elle accueillir des usines d'ASML Holding? Mécontent des propositions du nouveau gouvernement visant à freiner l'afflux d'étudiants étrangers et à réduire les allégements fiscaux qui attirent les expatriés aux Pays-Bas, le géant néerlandais considérerait plusieurs options pour poursuivre son expansion à l'étranger, rapporte 'De Telegraaf'. Selon le quotidien cité par 'Bloomberg', de hauts responsables du gouvernement néerlandais travaillent sur un plan visant à empêcher l'entreprise la plus valorisée d'Europe de déplacer davantage d'opérations en dehors des Pays-Bas.

Back in September 2023, analysts concluded the executive summary of Yole Group’s MicroLED 2023 report by saying that Apple’s smartwatch project was the incubator, not only for the company but for the entire industry, and that failure would be a devastating, if not fatal blow to the industry. Another key message that Yole Group’s display team conveyed to the microLED industry Association and at various events was that as microLEDs kept being delayed while OLED continued improving on all fronts (cost, performance, capacity), microLED’s value proposition was shrinking. Through 2023 discussion at Yole Group, to prepare this report, analysts sensed a palpable sense of urgency among industry players to accelerate microLED commercialization before OLED became too entrenched in the key applications it was targeting.

Experts are divided on whether or not exosomes are ready to be used as therapeutics. Theresa Whiteside, a professor of immunology at the University of Pittsburgh who studies the use of exosomes as tumor biomarkers, does not believe exosome-based therapeutics are ready for clinical study. “We have no idea what regulates [exosome biology],” Whiteside told BioSpace. “At the moment, it's a confusing picture.” In the other camp, Sharanjot Saini, an associate professor in the department of biochemistry and molecular biology at Augusta University, is using exosomes to deliver drugs for neuroendocrine prostate cancer. Exosomes engineered by Saini’s lab to specifically deliver two drugs to the prostate “significantly” reduced tumor growth in mouse studies. Saini told BioSpace that if initial safety and toxicity tests are conducted with rigor, there is nothing standing in the way of using exosomes as therapeutics.

D’un côté, nous pourrions considérer que faute de pouvoir contraindre nos partenaires internationaux à adopter le RGPD, la Commission européenne soumet les entreprises qui opèrent au sein de l’UE à des surcoûts relatifs qui affectent leur compétitivité. De l’autre, nous pourrions aussi considérer que la Commission européenne a urgé les entreprises à effectuer des investissements forcés susceptibles, in fine, d’améliorer la qualité des données en leur possession. Or, nous savons que ces données hautement qualifiées sont valorisées et indispensables aux services et produits faisant appel à l’IA. Ainsi, ce qui ressemble à un handicap initial pourrait se muer en avantage concurrentiel à terme.

Innovation drives productivity, and productivity is what drives jobs growth and the wealth that pays for our health, education, defence and social security systems. In short, innovation really matters. Governments, businesses and academics obsess over it. We need to know what works, what doesn’t and why - and that means turning to measurements and metrics. But can we really measure innovation today? Are we doing it right, or are our metrics more suited to Industry 2.0 and 3.0, rather than 4.0?

Repensez votre façon de créer avec le Studio magique, notre suite d’outils s’appuyant sur l’IA. Générez des textes fidèles à votre voix de marque avec Écriture magique ou transformez vos photos avec Édition magique.

Incertitudes économiques et géopolitiques, reports de grandes opérations informatiques, l'attentisme prévaut chez les clients des Big four et leader du conseil. Seul l'effet d'entraînement du marché du développement durable fait consensus.

A federal judge disagreed with AstraZeneca’s claims that the Inflation Reduction Act causes harm by disincentivizing innovation and violates its constitutional rights to due process. Blockbuster AstraZeneca drug Farxiga is one of 10 medications selected for the Medicare drug price negotiation program created by the law.

In January of 2019, The Predictive Index™ surveyed 156 CEOs, presidents, and chairpeople. We asked a slew of questions that cut to the heart of what drives them, what their challenges are, and what keeps them up at night. Their answers revealed the patterns of high-performing CEOs and allowed us to explore the executives’ inner thoughts and biggest weaknesses.

Transformez le chaos informationnel en connaissances actionnables grâce à un deuxième cerveau IA alimenté avec vos données. Bienvenue dans le monde du RAG avec l'outil génial d'une jeune startup française.

The field of Medical Technology (MedTech) is on an exciting trajectory, with innovations poised to revolutionize healthcare in 2024 and beyond. From cutting-edge medical devices to groundbreaking digital solutions, the intersection of medicine and technology continues to enable a more patient-centric future. Here are five MedTech trends to watch in 2024.

Convergence has revolutionized the way that the Financial Services community uses data by independently creating proprietary data-driven insights that support their revenue growth, efficiency and non-investment risk objective

Le spécialiste des centres d'appels chute lourdement à la Bourse de Paris, le marché s'inquiétant des répercussions sur son activité de l'essor d'outil d'IA de Klarna qui a effectué en un mois l'équivalent de 700 équivalents temps plein

A few days ago, Apple decided to cancel its microLED project with ams-Osram, a development that took the display industry by surprise. It certainly surprised ams-Osram, which announced it will have to re-assess its microLED strategy and incur $650-900 million in impairment charges. It is currently unclear whether Apple's decision was to completely abandon microLED technologies, or if it still in the microLED race, perhaps with different technologies and suppliers. It is likely that Apple does not have any immediate plans to introduce microLED displays, though. In this article, we'll try to analyze the reasons which led to Apple's decision and the probable implications for the microLED industry.

Two reports last week said that Apple’s micro-LED Apple Watch Ultra project was apparently cancelled, based on a statement by an Apple display supplier. These were based on one known fact: A company called AMS Osram said that big micro-LED project on which it was working was abruptly cancelled by the client.

Le blocage de votre entité innovation de rupture est le produit de quatre modèles mentaux erronés sur la nature de l'innovation.

Most of us now engage in activities ranging from internal process optimization to the development of new business models and revenue streams. This expansive scope underscores the increasing recognition of innovation as a comprehensive, company-wide endeavor rather than a siloed function. A critical challenge confronting innovation departments is demonstrating our value within the corporate. Moreover, it requires the ability to articulate and measure our impact in terms that resonate with stakeholders across the organization. How to do that?

Ava is the world’s best AI BDR. She takes care of the end-to-end B2B cold email sales process, finding hot leads.

Les multinationales spécialisées dans le conseil aiment faire croire qu’elles sont immunisées contre toute forme de ralentissement économique. Lorsqu’une source d’activité vient à se tarir, elles peuvent généralement compter sur les honoraires versés par des clients issus d’un autre secteur pour augmenter leur chiffre d’affaires. Mais ces champions supposés de l’adaptation sont aujourd’hui confrontés à des vents contraires imprévus.

In a connected world increasingly shaped by technology, data quality has emerged as a linchpin for organizational competitiveness and innovation. Accurate and reliable data not only empowers enterprises to make informed choices, but also forms the basis for building robust customer relationships and fostering strategic growth.

It’s a question consultants ask again and again: What do CEOs really want? The 2019 CEO Benchmarking Report revealed what CEOs value in consulting services. It also identified several areas in which consulting has failed them.

La création d'images de qualité ne nécessite pas toujours un investissement financier. Découvrez comment ces outils IA gratuits rendent la création accessible à tous.

Les directeurs et analystes financiers pourront bientôt utiliser un assistant à base d'IA, baptisé Copilot for Finance. Microsoft assure que son produit n'invente pas de chiffres, et qu'il peut soulager les professionnels de la finance en effectuant les tâches les plus pénibles.

Aux États-Unis, McKinsey est une nouvelle fois sur la sellette. Les républicains demandent d’exclure la firme des contrats fédéraux, en raison de son rôle – supposé – dans un groupe de réflexion ayant œuvré auprès des autorités chinoises. McKinsey dément catégoriquement. Une affaire qui se déroule à 9 mois de l’élection présidentielle américaine.